Skip to main navigation Skip to search Skip to main content

Efavirenz as a potential drug for the treatment of triple-negative breast cancers

    Research output: Contribution to journal › Article › peer-review

    15 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Efavirenz as a potential drug for the treatment of triple-negative breast cancers'. Together they form a unique fingerprint.
    Sort by

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science

    Biochemistry, Genetics and Molecular Biology